Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion type Assertion NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_head.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion description "[Moderately intensive warfarin therapy (international normalized ratio 2.0-3.0) could generally reduce the frequency of recurrent thrombotic events by at least 2-fold as compared with that before warfarin administration. The efficiency of using warfarin al]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion evidence source_evidence_literature NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion SIO_000772 20597268 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion wasDerivedFrom gad-20150221 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.
- NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_assertion wasGeneratedBy ECO_0000203 NP180395.RAsQxKihlv_ZdsKmqP-ojctUdO8BJuN_2p1XsW16QvXHI130_provenance.